Investors Purchase High Volume of Call Options on Xylem (NYSE:XYL)

Xylem Inc. (NYSE:XYL) was the target of some unusual options trading activity on Thursday. Traders purchased 20,508 call options on the company. This represents an increase of 771% compared to the average volume of 2,355 call options.

Wall Street Analysts Forecast Growth

XYL has been the topic of several research reports. The Goldman Sachs Group reduced their price target on shares of Xylem from $160.00 to $138.00 and set a “buy” rating on the stock in a research report on Wednesday. Royal Bank Of Canada lowered their price target on Xylem from $135.00 to $125.00 and set an “outperform” rating for the company in a research note on Wednesday. Barclays lowered Xylem from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $139.00 to $104.00 in a report on Wednesday. Oppenheimer reduced their price target on shares of Xylem from $150.00 to $135.00 and set an “outperform” rating for the company in a report on Wednesday. Finally, Wolfe Research initiated coverage on Xylem in a research report on Tuesday, September 15th. They set a “peer perform” rating for the company. Nine investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $121.31.

Xylem Trading Up 1.8%

NYSE XYL opened at $92.41 on Friday. Xylem has a twelve month low of $87.40 and a twelve month high of $152.43. The business’s fifty day moving average is $105.05 and its 200 day moving average is $117.57. The company has a quick ratio of 1.24, a current ratio of 1.39 and a debt-to-equity ratio of 0.23. The company has a market cap of $21.19 billion, a price-to-earnings ratio of 20.44, a price-to-earnings-growth ratio of 1.51 and a beta of 1.00.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a return on equity of 12.06% and a net margin of 11.94%. The business had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.28 billion. During the same quarter last year, the firm posted $1.37 EPS. Xylem’s revenue for the quarter was down 3.0% on a year-over-year basis. As a group, sell-side analysts expect that Xylem will post 5.45 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were paid a $0.43 dividend. The ex-dividend date was Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.9%. Xylem’s dividend payout ratio is currently 40.95%.

Insider Activity

In other news, Director D Koch bought 11,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 29th. The shares were acquired at an average cost of $89.60 per share, with a total value of $985,600.00. Following the completion of the transaction, the director directly owned 12,247 shares in the company, valued at $1,097,331.20. This represents a 882.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.32% of the company’s stock.

Hedge Funds Weigh In On Xylem

A number of hedge funds and other institutional investors have recently bought and sold shares of XYL. State Street Corp boosted its position in Xylem by 2.4% in the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock valued at $1,352,874,000 after buying an additional 270,972 shares during the last quarter. XXEC Inc. lifted its holdings in shares of Xylem by 477.9% in the 1st quarter. XXEC Inc. now owns 171,211 shares of the industrial products company’s stock worth $20,460,000 after purchasing an additional 141,586 shares during the last quarter. Perpetual Ltd boosted its stake in Xylem by 10.2% during the 3rd quarter. Perpetual Ltd now owns 129,946 shares of the industrial products company’s stock valued at $13,160,000 after purchasing an additional 11,993 shares during the period. NFJ Investment Group LLC acquired a new stake in Xylem in the 2nd quarter valued at approximately $4,116,000. Finally, TD Waterhouse Canada Inc. lifted its holdings in Xylem by 1,922.6% in the second quarter. TD Waterhouse Canada Inc. now owns 46,034 shares of the industrial products company’s stock worth $5,400,000 after purchasing an additional 43,758 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem News Summary

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
• Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
• Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
• Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
• Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
• Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.